Vuse: BAT's E-Liquid Enters Korean E-Cigarette Market

VUSE by 2FIRSTS.ai
Dec.11.2023
Vuse: BAT's E-Liquid Enters Korean E-Cigarette Market
BAT Korea introduced 'Vuse' in the Korean market, aiming to compete with KT&G's Lil and PMI's IQOS.

On December 10th, according to Naver news, Eunji Kim, the CEO of British American Tobacco (BAT) Korea, introduced 'Vuse' to the Korean market. Currently, BAT ranks third in the domestic e-cigarette market in South Korea (where HNB products are considered e-cigarettes), following KT&G's Lil and PMI's IQOS.

 

According to Kim Eun-jee, "Lil and IQOS are tobacco while Vuse is an e-liquid. Vuse has proven its competitiveness in the US market, so it should be able to challenge the current status quo.

 

The newly launched 'Vuse Go 800' has sold out within a month of its release. It is reported that in the first week after the initial batch of products hit the market, Vuse's market share in the e-cigarette market in Korea increased by approximately four times, prompting plans to expand sales nationwide from next year.

 

Kim En-zhi emphasized that the key marketing point of Vuse is its safety. Apart from the e-liquid produced in the manufacturing phase, users are not allowed to randomly change the internal e-liquid.

 

She said, "It is difficult for us to accurately know what ingredients are added in e-cigarettes sold through numerous informal channels. Once the safety of Vuse is known, the threat to users' health from using e-cigarettes will disappear.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress demands FDA allocate at least $200 million for ENDS enforcement; multi-agency task force to combat illegal e-cigarette imports.
Nov.18 by 2FIRSTS.ai
PouchEx Stockholm 2025 — Where the Future of Oral Innovation Begins
PouchEx Stockholm 2025 — Where the Future of Oral Innovation Begins
PouchEx Stockholm 2025 is coming to Sweden, bringing together leading brands, technologies, and thought leaders to explore the future of smoke-free innovation. It will be one of the must-attend nicotine pouch events of 2025. 2Firsts is one of the official media partners of the event.
Oct.11
NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations
NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations
New Zealand’s High Alert drug harm monitoring system has issued a public High Alert warning after multiple hospitalisations linked to illicit vape pods containing the anaesthetic etomidate. Known on the street as space oil, k-pods, or eto, these vapes were first detected in January 2025. Customs has since seized additional samples, and clinics nationwide report rising cases of poisoning and hypoglycaemia.
Nov.04 by 2FIRSTS.ai
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) reported that from Sep 1 to Oct 12, 1,339 people were caught for vape-related offences, including 102 found in possession of etomidate-laced vapes.
Oct.17 by 2FIRSTS.ai
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
U.S. District Judge William Orrick of the Northern District of California indicated on Friday that he will likely certify classes of direct and indirect purchasers accusing e-cigarette makers Juul Labs Inc. and former rival Altria Group Inc. of conspiring to limit product variety and violate antitrust laws.
Oct.20 by 2FIRSTS.ai
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.
Nov.18 by 2FIRSTS.ai